Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids. [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial comparing bevacizumab versus triamcinolone acetonide for the treatment of keloids. The study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)
  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Keloids | Phase 4 | Status: ACTIVE_NOT_RECRUITING